Stock Price & Analysis

Based on the recent data and market activity, IDEX Corporation (IEX) is showing signs of being oversold with an RSI of 28.1, suggesting potential buying opportunity at current levels, but the weak Q1 guidance and recent price decline warrant caution.

Technical Analysis

• Stock is currently trading at $196.45, showing a modest gain of +0.26% in today's session
• RSI at 28.1 indicates oversold conditions
• Currently trading below its 20-day SMA of $214.52, suggesting bearish short-term momentum

Recent Events & Performance

• Stock fell 12.65% last week following mixed Q4 financial results
• Q4 adjusted EPS came in at $2.04, slightly above consensus of $2.03
• Company provided weak Q1 guidance of $1.60-$1.65 EPS, significantly below consensus of $2.03

Analyst Sentiment

• Recent price target adjustments:
  • RBC Capital: Lowered to $245 from $256, maintains Buy rating
  • Citigroup: Maintains Buy rating with $267 target
• Consensus remains bullish with multiple analysts seeing significant upside potential

Fibonacci Levels

• Key support at $197.91 (S1)
• Resistance at $222.79 (R1)
• Current price near S1 support level, suggesting potential stabilization point

Recommendation SELL. Despite oversold conditions and analyst optimism, the significant guidance miss, technical weakness, and broader market uncertainty suggest waiting for signs of stabilization before entering. The stock could see further downside as it digests the weak guidance and adjusts to new market expectations.

Based on the provided data and recent analyst reports, here's the price prediction for IEX stock in 2025:

IEX stock is expected to reach $245 by year-end 2025, supported by RBC Capital's recent price target adjustment and positive outlook on the company's recovery potential. The stock is currently trading at $196.45, with technical indicators showing an RSI of 30.29 suggesting oversold conditions, presenting a potential upside opportunity. The return of blanket orders and expected second-half weighted performance in 2025 provides additional support for this target.

The S1 support level for IEX Stock is $197.03 ,The R1 resistant level for IEX Stock is $221.91.

As of the end of day on 2025-02-11, the price of IEX Stock was $194.89.

The target price for IEX Stock according to analyst rating is 235.75, with the highest price target at 264.00 and the lowest at 200.00. Analysts have a Strong Buy rating on IEX Stock overall.

The market cap of IEX is $14.8B.

Based on the provided data and recent market events, IDEX Corporation appears overvalued at current levels. The company's Q4 2024 results showed mixed performance with an operating miss and below-consensus guidance. The stock has experienced significant selling pressure, falling 12.65% following its latest earnings report. The current P/E ratio of 31.46x is notably higher than historical averages, while EV/EBITDA at 19.94x suggests premium valuation compared to industrial sector peers.

The company's net margin has declined from 15.15% in Q1 2024 to 14.28% in Q4 2024, while debt-to-equity ratio increased significantly from 36.58% to 51.66% over the same period, indicating deteriorating financial metrics. Recent analyst actions reflect growing concerns - RBC Capital lowered their price target from $256 to $245, citing operational challenges and weak Q1 guidance.

The technical chart shows a clear downward trend, with the stock breaking below key support levels. The recent sharp decline following earnings suggests institutional investors are reassessing their positions given the company's guidance and operational headwinds.

While analysts maintain a generally positive long-term outlook with an average price target of $254.75, the current valuation multiples, declining margins, increasing leverage, and technical weakness indicate the stock is overvalued at current levels. The combination of premium valuation metrics and deteriorating fundamentals suggests potential further downside risk in the near term.

IDEX Corporation is an applied solutions company. Its segments include Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors and other fluid-handling pump modules and systems and provides flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agriculture and energy industries. The HST segment designs, produces and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and others. The FSDP segment designs, produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags and other components and systems.

Based on the recent market data and analyst forecasts, IDEX Corp (IEX) is projected to reach $285-295 by 2030, driven by its strategic acquisitions like Mott Corp and continued expansion in industrial automation sectors. Recent challenges including higher employee costs and Q4 operating miss have led to near-term price target adjustments, with RBC Capital lowering targets to $245 while maintaining an Outperform rating. The company's strong market position in industrial fluid systems and fire safety equipment, combined with the return of blanket orders, suggests a positive long-term growth trajectory despite current headwinds.

IEX has a total of 8800 employees.